FIELD: chemistry.
SUBSTANCE: invention relates to bifunctional compounds which contain on one end a ligand binding to ubiquitin ligase E3, and at the other end a fragment which binds to the target protein, so that the target protein is found near ubiquitin ligase, which degrades (and inhibits) said protein.
EFFECT: compounds are intended for preparing a composition for degradation of BET bromodomain-containing protein or ERRα in a cell.
7 cl, 21 dwg, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
IMIDE MODULATORS OF PROTEOLYSIS AND METHODS FOR USING THEM | 2015 |
|
RU2738833C2 |
CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS CONTAINING THEM | 2018 |
|
RU2795146C2 |
ISOINDOLINE COMPOUNDS USED FOR TREATING CANCER | 2009 |
|
RU2527952C2 |
THIENOPYRROL DERIVATIVES FOR APPLICATION FOR TARGETING PROTEINS, COMPOSITIONS WITH SAID DERIVATIVES, METHODS AND APPLICATIONS | 2017 |
|
RU2771166C2 |
COMPOUND BASED ON PYRROLAMIDOPYRIDONE, METHOD OF ITS PREPARATION AND USE | 2020 |
|
RU2809596C2 |
COMPOUNDS TARGETING TAU PROTEIN AND RELATED USE THEREOF | 2017 |
|
RU2805523C2 |
MDM2 PROTEIN DESTRUCTORS | 2017 |
|
RU2743432C2 |
COMPOUNDS AND METHODS FOR ENHANCED DEGRADATION OF TARGET PROTEINS AND OTHER POLYPEPTIDES BY AN E3 UBIQUITIN LIGASE | 2013 |
|
RU2666530C2 |
BIVALENT BROMODOMAIN INHIBITORS AND ROUTES OF USE THEREOF | 2016 |
|
RU2742035C2 |
PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
Authors
Dates
2019-10-31—Published
2016-06-03—Filed